safety working group

Purpose: To establish recommendations and guidelines for safety of transcranial ultrasonic stimulation (TUS) neuromodulation in humans, including contraindications and reporting of adverse events. We will start from a safety guideline on testing healthy humans and expand (later) to patient-/disease-specific guidelines. We will also start from single-session testing and expand (later) to multi-session guidelines.

short-term goals

  • To report on a review of literature concerning TUS safety
  • To recommend a metric for mechanical and thermal safety (in collaboration with the Reporting and Planning focus groups)
  • To recommend exclusion/inclusion criteria for healthy volunteers and patients (in collaboration with the Clinical focus group)

1 year goals (06/2022)

  • To provide guidelines for mechanical and thermal safety
  • To provide guidelines for exclusion/inclusion criteria for healthy volunteers and patients

members

First name Last name Primary affiliation Country
Jean-Francois Aubry National Centre for Scientific Research France
Seung-Schik Yoo Harvard University USA
Andrew Thomas Brainbox Ltd. UK
Anton Fomenko University of Toronto Canada
Charles Caskey Vanderbilt University, Insitute of Imaging Science USA
Charlotte Stagg University of Oxford UK
Christopher Butler University of Oxford, Imperial College London UK
David Attali ESPCI France
Ellen Bubrick Brigham and Women’s Hospital USA
Elsa Fouragnan Plymouth University UK
Fidel Vila-Rodriguez The University of British Colombia Canada
Ghazal Darmani Toronto Canada
Jerome Sallet INSERM, university of Oxford UK
Kim Butts Pauly Stanford University USA
Lennart Verhagen Donders Institute The Netherlands
Mark Schafer Drexel University/Brainsonix USA
Robert Chen University Health Network Canada

Table of contents